Company Name, Ticker, Competitors, else..

Bellicum Pharmaceuticals Inc (BLCM)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Bellicum Pharmaceuticals Inc 's

Name: Bellicum Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BLCM Sales vs. its Competitors Q3 2023

Comparing the current results to its competitors, Bellicum Pharmaceuticals Inc reported Revenue decrease in the 3 quarter 2023 year on year by -0.89 %, despite the revenue increase by the most of its competitors of 2.09 %, recorded in the same quarter.

• List of BLCM Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Bellicum Pharmaceuticals Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 186.59 %

<< BLCM Stock Performance Comparisons

<< See the full list of BLCM competitors

Overall company Market Share Q3 2023

Overall company, revenue fell by -0.89 % and company lost market share, to approximately 0 %. << More on BLCM Market Share.

*Market share is calculated based on total revenue.

BLCM's Stock Performance relative to its Competitors

Publicly Traded Peers of Bellicum Pharmaceuticals Inc

Sio Gene Therapies Inc
Share Performance

+22.88%

30 Days

Sio Gene Therapies Inc

Profile

Sio Gene Therapies Inc operates with a business model focused on developing and commercializing gene therapies to treat and potentially cure various neurological genetic diseases. Their approach involves leveraging cutting-edge gene therapy technology to address unmet medical needs and improve patients' quality of life.

More about Sio Gene Therapies Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 35.360 mill.	$ - mill.	$ -28.829 mill.

Vincerx Pharma Inc
Share Performance

0.00%

This Year

Vincerx Pharma Inc

Profile

Vincerx Pharma Inc's business model is focused on developing and commercializing novel small molecule drugs for the treatment of cancer. They aim to leverage their scientific expertise and collaborations to identify and advance promising drug candidates, ultimately providing innovative therapies to patients in need.

More about Vincerx Pharma Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.047 mill.	$ - mill.	$ -22.645 mill.

Spero Therapeutics Inc
Share Performance

-6.15%

Over The Past 5 Days

Spero Therapeutics Inc

Profile

Spero Therapeutics Inc's business model focuses on developing novel antibiotics to combat drug-resistant bacterial infections.

More about Spero Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 66.374 mill.	$ - mill.	$ 7.383 mill.

Sonnet Biotherapeutics Holdings Inc
Share Performance

-36.88%

One Year

Sonnet Biotherapeutics Holdings Inc

Profile

Sonnet Biotherapeutics Holdings Inc's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of cancer and other diseases.

More about Sonnet Biotherapeutics Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 5.204 mill.	$ - mill.	$ -16.011 mill.

Whitehawk Therapeutics Inc
Share Performance

+71.31%

This Year

Whitehawk Therapeutics Inc

Profile

The company is a clinical-stage oncology therapeutics firm focused on developing antibody-drug conjugates for cancer treatment.

More about Whitehawk Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 346.464 mill.	$ 1.469 mill.	$ -79.831 mill.

136 more competitors available

Sources: Bellicum Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:31 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bellicum Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.